Type 2 myocardial infarction due to supply–demand mismatch

Trends in Cardiovascular Medicine

Volumn 27, Issue 6, 2017, Pages 408-417

  Mihatov, Nino ^a   Januzzi, James L ^a,b,c   Gaggin, Hanna K ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Type 2 myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; OXYGEN;

ANGIOGRAPHY; ANTICOAGULANT THERAPY; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE NECROSIS; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; BLOOD; CARDIAC MUSCLE; CLASSIFICATION; CORONARY ARTERY BLOOD FLOW; METABOLISM; MYOCARDIAL INFARCTION; NECROSIS; NOMENCLATURE; OXYGEN CONSUMPTION; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; TISSUE SURVIVAL;

ANIMALS; CORONARY CIRCULATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; OXYGEN; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TERMINOLOGY AS TOPIC; TISSUE SURVIVAL;

EID: 85018729712     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2017.03.002     Document Type: Review

References (41)

1. Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60 (2012), 1581–1598.
2. Saaby, L., Poulsen, T.S., Diederichsen, A.C., Hosbond, S., Larsen, T.B., Schmidt, H., et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 127 (2014), 295–302.
3. Sandoval, Y., Thordsen, S.E., Smith, S.W., Schulz, K.M., Murakami, M.M., Pearce, L.A., et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care 3 (2014), 317–325.
4. Saaby, L., Poulsen, T.S., Hosbond, S., Larsen, T.B., Pyndt Diederichsen, A.C., Hallas, J., et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 126 (2013), 789–797.
5. Javed, U., Aftab, W., Ambrose, J.A., Wessel, R.J., Mouanoutoua, M., Huang, G., et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 104 (2009), 9–13.
6. Baron, T., Hambraeus, K., Sundstrom, J., Erlinge, D., Jernberg, T., Lindahl, B., et al. Type 2 myocardial infarction in clinical practice. Heart 101 (2015), 101–106.
7. Morrow, D.A., Wiviott, S.D., White, H.D., Nicolau, J.C., Bramucci, E., Murphy, S.A., et al. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation 119 (2009), 2758–2764.
8. Melberg, T., Burman, R., Dickstein, K., The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol 139 (2010), 228–233.
9. Stein, G.Y., Herscovici, G., Korenfeld, R., Matetzky, S., Gottlieb, S., Alon, D., et al. Type-II myocardial infarction—patient characteristics, management and outcomes. PLoS One, 9, 2014, e84285.
10. Meigher, S., Thode, H.C., Peacock, W.F., Bock, J.L., Gruberg, L., Singer, A.J., Causes of elevated cardiac troponins in the emergency department and their associated mortality. Acad Emerg Med 23 (2016), 1267–1273.
11. Gaggin, H.K., Liu, Y., Lyass, A., van Kimmenade, R., Motiwala, S.R., Kelly, N.P., et al. Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography. Circulation 135:2 (2017), 116–127.
12. Sandoval, Y., Smith, S.W., Thordsen, S.E., Apple, F.S., Supply/demand type 2 myocardial infarction: should we be paying more attention?. J Am Coll Cardiol 63 (2014), 2079–2087.
13. Shah, A.S., McAllister, D.A., Mills, R., Lee, K.K., Churchhouse, A.M., Fleming, K.M., et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med 128 (2015), 493–501 [e3].
14. Gualandro, D.M., Campos, C.A., Calderaro, D., Yu, P.C., Marques, A.C., Pastana, A.F., et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis 222 (2012), 191–195.
15. Mahmoud, K.D., Sanon, S., Habermann, E.B., Lennon, R.J., Thomsen, K.M., Wood, D.L., et al. Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery. J Am Coll Cardiol 67 (2016), 1038–1049.
16. Landesberg, G., Mosseri, M., Shatz, V., Akopnik, I., Bocher, M., Mayer, M., et al. Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. J Am Coll Cardiol 44 (2004), 569–575.
17. Fleisher, L.A., Nelson, A.H., Rosenbaum, S.H., Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease?. J Clin Anesth 7 (1995), 97–102.
18. Braunwald, E., 50th anniversary historical article. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout. J Am Coll Cardiol 35:5 Suppl. B (2000), S45B–S48B.
19. Szymanski, F.M., Karpinski, G., Platek, A.E., Majstrak, F., Hrynkiewicz-Szymanska, A., Kotkowski, M., et al. Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction. Kardiol Pol 72 (2014), 339–344.
20. Najib, K., Boateng, S., Sangodkar, S., Mahmood, S., Whitney, H., Wang, C.E., et al. Incidence and characteristics of patients presenting with acute myocardial infarction and non-obstructive coronary artery disease. Catheter Cardiovasc Interv 86:Suppl. 1 (2015), S23–S27.
21. Alpert, J.S., Thygesen, K.A., White, H.D., Jaffe, A.S., Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 127 (2014), 105–108.
22. Sandoval, Y., Thygesen, K., Myocardial infarction type 2 and myocardial injury. Clin Chem 63 (2017), 101–107.
23. White, H.D., Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?. J Am Coll Cardiol 57 (2011), 2406–2408.
24. Smith, S.C., Ladenson, J.H., Mason, J.W., Jaffe, A.S., Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95 (1997), 163–168.
25. Horwich, T.B., Patel, J., MacLellan, W.R., Fonarow, G.C., Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003), 833–838.
26. Feng, J., Schaus, B.J., Fallavollita, J.A., Lee, T.C., Canty, J.M. Jr, Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103 (2001), 2035–2037.
27. Maeder, M., Fehr, T., Rickli, H., Ammann, P., Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129 (2006), 1349–1366.
28. Pathan, N., Hemingway, C.A., Alizadeh, A.A., Stephens, A.C., Boldrick, J.C., Oragui, E.E., et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 363 (2004), 203–209.
29. Kumar, A., Thota, V., Dee, L., Olson, J., Uretz, E., Parrillo, J.E., Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (1996), 949–958.
30. Wu, A.H., Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression?. Intensive Care Med 27 (2001), 959–961.
31. Cunnion, R.E., Schaer, G.L., Parker, M.M., Natanson, C., Parrillo, J.E., The coronary circulation in human septic shock. Circulation 73 (1986), 637–644.
32. Turner, A., Tsamitros, M., Bellomo, R., Myocardial cell injury in septic shock. Crit Care Med 27 (1999), 1775–1780.
33. Landesberg, G., Vesselov, Y., Einav, S., Goodman, S., Sprung, C.L., Weissman, C., Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med 33 (2005), 1281–1287.
34. Reichlin, T., Hochholzer, W., Bassetti, S., Steuer, S., Stelzig, C., Hartwiger, S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361 (2009), 858–867.
35. Korley, F.K., Jaffe, A.S., Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol 61 (2013), 1753–1758.
36. Sandoval, Y., Smith, S.W., Schulz, K.M., Murakami, M.M., Love, S.A., Nicholson, J., et al. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system. Clin Chem 61 (2015), 657–663.
37. Ambrose, J.A., Loures-Vale, A., Javed, U., Buhari, C.F., Aftab, W., Angiographic correlates in type 1 and 2 MI by the universal definition. JACC Cardiovasc Imaging 5 (2012), 463–464.
38. Chokshi, N.P., Iqbal, S.N., Berger, R.L., Hochman, J.S., Feit, F., Slater, J.N., et al. Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes. Clin Cardiol 33 (2010), 495–501.
39. Mohammed, A.A., Yang, A., Shao, K., Disabatino, A., Blackwell, R., Banbury, M., et al. Patients with left main coronary artery vasospasm inadvertently undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 61 (2013), 899–900.
40. Bonaca, M.P., Wiviott, S.D., Braunwald, E., Murphy, S.A., Ruff, C.T., Antman, E.M., et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Circulation 125 (2012), 577–583.
41. Bonaca, M.P., Ruff, C.T., Kosowsky, J., Conrad, M.J., Murphy, S.A., Sabatine, M.S., et al. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care 2 (2013), 195–202.